EUVIMEDEUVIMED entdecken
Crossref

Drug-Induced Photosensitivity: Clinical and Etiological Study in Tunisia

Yasmine Salem Mahjoubi, Ons Charfi, Fatma Maroua Zgolli, Ahmed Zaiem, Ghozlane Lakhoua, Israa Dahmani, Sarrah Kastalli, Imen Aouinti, Sihem EL Aidli

Clinical Pharmacy Connect · 2025

DOI: 10.69709/cpc.2025.122134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacy Connect, 2025. Verfasst von Yasmine Salem Mahjoubi und 8 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Photosensitization refers to a cutaneous adverse reaction triggered by sunlight exposure. It manifests either as phototoxicity or as photoallergy, the latter representing an immune-mediated hypersensitivity reaction. This study aimed to describe the epidemiological and clinical characteristics of patients with drug-induced photosensitivity in Tunisia and to identify the implicated medications.

Methods

We conducted a retrospective analysis of all cases of drug-induced photosensitivity reported to the National Pharmacovigilance Center (CNPV) over 11 years.

Results

A total of 130 cases were analyzed. The median age was 58 years (range: 8–83), with a female-to-male ratio of 1.95. Time to onset of symptoms after drug intake ranged from 6 h to 20 years, with a median of 60 days. Phototoxic reactions represented 81.5% of cases, most commonly presenting as erythema (84.9%). Photoallergic reactions predominantly manifested as eczema, localized to photo-exposed areas in 18 cases, and expanded to covered regions, such as the trunk and back, in 6 cases. Clinical improvement following drug withdrawal was observed in 61.5% of patients. The most frequently implicated drug classes were cardiovascular medications (46.7%) and anti-infectives (16.9%).

Conclusion

Although relatively uncommon, drug-induced photosensitivity should be promptly recognized by clinicians, as it can result in cosmetic and medical complications. Early discontinuation of the causative drug usually ensures resolution, while strict photoprotection remains essential to prevent recurrences. Importantly, chronic or recurrent photosensitization can elevate the long-term risk of photocarcinogenesis, emphasizing the need for careful monitoring and preventive measures during high-risk therapies.

Zitieren

APA

Mahjoubi, Y. S., Charfi, O., Zgolli, F. M., Zaiem, A., Lakhoua, G., Dahmani, I., Kastalli, S., Aouinti, I., & Aidli, S. E. (2025). Drug-Induced Photosensitivity: Clinical and Etiological Study in Tunisia. Clinical Pharmacy Connect. https://doi.org/10.69709/cpc.2025.122134

Vancouver

Mahjoubi YS, Charfi O, Zgolli FM, Zaiem A, Lakhoua G, Dahmani I, et al. Drug-Induced Photosensitivity: Clinical and Etiological Study in Tunisia. Clinical Pharmacy Connect. 2025. doi:10.69709/cpc.2025.122134

BibTeX
@article{Mahjoubi2025,
  author = {Mahjoubi, Yasmine Salem and Charfi, Ons and Zgolli, Fatma Maroua and Zaiem, Ahmed and Lakhoua, Ghozlane and Dahmani, Israa and Kastalli, Sarrah and Aouinti, Imen and Aidli, Sihem EL},
  title = {Drug-Induced Photosensitivity: Clinical and Etiological Study in Tunisia},
  journal = {Clinical Pharmacy Connect},
  year = {2025},
  doi = {10.69709/cpc.2025.122134}
}
Kostenlos starten →